P-43 Randomised phase III trial of docetaxel/carboplatin vs. MIC/MVP chemotherapy in inoperable Advanced non-small cell lung cancer (NSCLC) — Do XPD polymorphisms predict for sensitivity or resistance to platinum based chemotherapy
Booton, Richard, Campbell, Daniel, Ward, Tim, Ashcroft, L., Power, Fiona, Taylor, Pat, Burt, Paul, Wierenga, Gilbert, Thathcer, Nicholas
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2003)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2003)
Get full text
Journal Article